A clinical study of the efficacy of a single session of individual exercise for depressive patients, assessed by the change in saliva free cortisol level

BioPsychoSocial Medicine

Volumn 7, Issue 1, 2013, Pages

  Ida, Megumi ^a   Ida, Itsurou ^b   Wada, Naoki ^c   Sohmiya, Makoto ^a   Tazawa, Masayuki ^c   Shirakura, Kenji ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION TAKASAKI GENERAL MEDICAL CENTER   (Japan)

^c GUNMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Augmentation therapy; Depression; Physical exercise; Quality of life; Saliva free cortisol level

Indexed keywords

EID: 84888988771     PISSN: None     EISSN: 17510759     Source Type: Journal    
DOI: 10.1186/1751-0759-7-18     Document Type: Article

References (39)

1. World Health Organization International classification of diseases 10th revision. http://www.who.int/classifications/icd/en/bluebook.pdf, World Health Organization.
2. World Health Organization The World Health report 2001 Mental Health: new understanding, new hope. http://www.who.int/whr/2001/en/whr01_en.pdf, World Health Organization.
3. Kennard BD, Silva SG, Tonev S, Rohde P, Hughes JL, Vltiello B, Kratochvil CJ, Curry JF, Emslie GJ, Reinecke M, March J. Remission and recovery in the Treatment for Adolescents with Depression Study (TADS): acute and long-term outcomes. J Am Acad Child Adolesc Psychiatry 2009, 48:186-195. 10.1097/CHI.0b013e31819176f9, 2843506, 19127172.
4. Angst J. The course of affective disorders. Psychopathology 1986, 19(Suppl 2):47-52.
5. Keller MB, Lavori PW, Mueller TI, Endicott J, Coryell W, Hirschfeld RMA, Shea T. Time to recovery, chronicity, and levels of psychopathology in major depression: a 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry 1992, 49:809-816. 10.1001/archpsyc.1992.01820100053010, 1417434.
6. Judd LL, Akiskal HS, Zeller PJ, Paulus M, Leon AC, Maser JD, Endicott J, Coryell W, Kunovac JL, Muller TI, Rice JP, Leller MB. Psychosocial disability during the long-term course of unipolar major depressive disorder. Arch Gen Psychiatry 2000, 57:375-380. 10.1001/archpsyc.57.4.375, 10768699.
7. ten Doesschate MC, Koeter MW, Bockting CL, Schene AH, . DELTA Study Group Health related quality of life in recurrent depression: a comparison with a general population sample. J Affect Disord 2010, 120:126-132. 10.1016/j.jad.2009.04.026, 19446342, DELTA Study Group.
8. World Health Organization The global burden of disease: 2004 update 2008. http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf, World Health Organization.
9. Morgan WP. Physical Activity and Mental Health 1997, Washington. DC: Taylor & Francis.
10. Paffenbarger RS, Lee IM, Leung R. Physical activity and personal characteristics associated with depression and suicide in American college men. Acta Psychiatr Scand 1994, 377:16-22.
11. Blumenthal JA, Babyak MA, Moore KA, Craighead WE, Herman S, Khatri P, Waugh R, Napolitano MA, Forman LM, Appelbaum M, Doraiswamy PM, Krishnan KR. Effects of exercise training on older patients with major depression. Arch Intern Med 1999, 159:2349-2356.
12. Mather AS, Rodriguez C, Guthrie MF, McHarg AM, Reid IC, Marion ET, McMurdo MT. Effects of exercise on depressive symptoms in older adults with poorly responsive depressive disorder. Br J Psychiatry 2002, 180:411-415. 10.1192/bjp.180.5.411, 11983637.
13. Blumenthal JA, Babyak MA, Doraiswamy PM, Watkins L, Hoffman BM, Barbour KA, Herman S, Craighead WE, Brosse AL, Waugh R, Hinderliter A, Sherwood A. Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med 2007, 69:587-596. 10.1097/PSY.0b013e318148c19a, 2702700, 17846259.
14. Hasler G. Pathophysiology of depression: do we have any solid evidence of interest to clinicians?. World Psychiatry 2010, 9:155-161. 2950973, 20975857.
15. Halbreich U, Asnis GM, Shindledecker R, Zumoff B, Nathan RS. Cortisol secretion in endogenous depression. I. Basal plasma levels. Arch Gen Psychiatry 1985, 42:904-908. 10.1001/archpsyc.1985.01790320076010, 4037990.
16. Stokes PE, Stoll PM, Koslow SH, Maas JW, Davis JM, Swann AC, Robins E. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups: a multicenter study. Arch Gen Psychiatry 1984, 41:257-267. 10.1001/archpsyc.1984.01790140047006, 6367690.
17. Holsboer F, von Bardeleben U, Wiedemann K, Müller OA, Stalla GK. Serial assessment of corticotoropin-releasing hormone response after dexamethasone in depression: implications for pathophysiology of DST nonsuppression. Biol Psychiatry 1987, 22:228-234. 10.1016/0006-3223(87)90237-X, 3028512.
18. Holsboer F, Lauer CJ, Schreiber W, Krieg JC. Altered hypothalamic-pituitary-adrenocortical regulation in health subjects at high familial risk for affective disorders. Neuroendocrinology 1995, 62:340-347. 10.1159/000127023, 8544947.
19. Kirschbaum C, Hellhammer DH. Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology 1994, 19:313-333. 10.1016/0306-4530(94)90013-2, 8047637.
20. First MB, Frances A, Pincus HA. DSM-IV-TR® Handbook of Differential Diagnosis 2002, Arlington: American Psychiatric Publishing.
21. Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehab Med 1970, 2:92-98.
22. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23:56-62. 10.1136/jnnp.23.1.56, 495331, 14399272.
23. Ware JE, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual 1994, Boston: Nimrod: The Health Data Institute of New England Medical Center.
24. Beusterien KM, Steinwald B, Ware JE. Usefulness of the SF-36 Health Survey in measuring health outcomes in the depressed elderly. J Geriatr Psychiatry Neurol 1996, 9:5-37.
25. Buist-Bouwman MA, De Graaf R, Vollebergh WA, Alonso J, Bruffaerts R, Ormel J, . ESEMeD/MHEDEA 2000 Investigators Functional disability of mental disorders and comparison with physical disorders: a study among the general population of six european countries. Acta Psychiatr Scand 2006, 113:429-500. ESEMeD/MHEDEA 2000 Investigators.
26. Buist-Bouwman MA, Ormel J, de Graaf R, de Jonge P, van Sonderen E, Alonso J, Bruffaerts R, Vollebergh WA, . ESEMeD/MHEDEA 2000 investigators Mediators of the association between depression and role functioning. Acta Psychiatr Scand 2008, 118:451-458. 10.1111/j.1600-0447.2008.01285.x, 3659780, 18853945, ESEMeD/MHEDEA 2000 investigators.
27. Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K. Translation, adaptation, and validation of the SF-36v2TM Health Survey for use in Japan. J Clin Epidemiology 1998, 51:1037-1044.
28. Fukuhara S, Ware JE, Kosinski M, Wada S, Gandek B. Psychometric and clinical tests of validity of the Japanese SF-36v2TM Health Survey. J Clin Epidemiology 1998, 51:1045-1053.
29. Fukuhara S, Suzukamo Y. SF-36v2 Japanese version 2004, Kyoto: Institute for Health Outcome and Process Evaluation Research.
30. The R project for statistical computing. http://www.r-project.org/.
31. Lam RW, Filteau MJ, Milev R. Clinical effectiveness: the importance of psychosocial functioning outcomes. J Affect Disord 2011, 132(Suppl 1):S9-S13.
32. Papakostas GI, Petersen T, Mahal Y, Mischoulon D, Nierenberg AA, Fava M. Quality of life assessments in major depressive disorder: a review of the literature. Gen Hosp Psychiatry 2004, 26:13-17. 10.1016/j.genhosppsych.2003.07.004, 14757297.
33. Saarni AI, Suvisaari J, Sintonen H, Pirkola S, Koskinen S, Aromaa A, Lönnqvist J. Impact of psychiatric disorders on health-related quality of life: general population survey. Br J Psychiatry 2007, 190:326-332. 10.1192/bjp.bp.106.025106, 17401039.
34. Keeley RD, Smith JL, Nutting PA, Dickinson LM, Dickinson WP, Kathryn M, Rost KM. Does a depression intervention result in improved outcomes for patients presenting with physical symptoms?. J Gen Intern Med 2004, 19:615-623. 10.1111/j.1525-1497.2004.30611.x, 1492378, 15209599.
35. Kiive E, Maaroos J, Shlik J, Tõru I, Harro J. Growth hormone, cortisol and prolactin responses to physical exercise: higher prolactin response in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:1007-1013. 10.1016/j.pnpbp.2004.05.035, 15380861.
36. Krogh J, Nordentoft M, Mohammad-Nezhad M, Westrin A. Growth hormone, prolactin and cortisol response to exercise in patients with depression. J Affect Disord 2010, 125:189-197. 10.1016/j.jad.2010.01.009, 20149929.
37. Deuschle M, Hamann B, Meichel C, Krumm B, Lederbogen F, Kniest A, Colla M, Heuser I. Antidepressive treatment with amitriptyline and paroxetine: effects on saliva cortisol concentrations. J Clin Psychopharmacol 2003, 23:201-205. 10.1097/00004714-200304000-00014, 12640223.
38. Hinkelmann K, Moritz S, Botzenhardt J, Muhtz C, Wiedemann K, Kellner M, Otte C. Changes in cortisol secretion during antidepressive treatment and cognitive improvement in patients with major depression: a longitudinal study. Psychoneuroendocrinology 2012, 37:685-692. 10.1016/j.psyneuen.2011.08.012, 21944955.
39. Scharnholz B, Weber-Hamann B, Lederbogen F, Schilling C, Gilles M, Onken V, Frankhauser P, Kopf D, Deuschle M. Antidepressant treatment with mirtazapine, but not venlafaxine, lowers cortisol concentrations in saliva: a randomised open trial. Psychiatry Res 2010, 177:109-113. 10.1016/j.psychres.2009.08.010, 20381159.